S. Evans

发表

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study

F. Hamdy, D. Neal, J. Donovan, 2017, BMJ Open.

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate CancerMortality The CAP Randomized Clinical Trial

J. Sterne, F. Hamdy, D. Neal, 2018 .

CAP Cause of Death Committee (2015). Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial: lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate

F. Hamdy, D. Neal, J. Donovan, 2015 .

Letter to the Editor

Y. Ben-Shlomo, C. Metcalfe, S. Evans, 2010, American journal of men's health.

The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study

D. Gillatt, D. Dorling, Y. Ben-Shlomo, 2008 .

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial

L. Holmberg, J. Oxley, J. Sterne, 2016, Trials.

Prostate cancer in Black and White men: are there differences in risk or prognosis?

Y. Ben-Shlomo, R. Persad, S. Evans, 2003, BJU international.

Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study

D. Gillatt, Y. Ben-Shlomo, C. Metcalfe, 2009, British Journal of Cancer.

Y. Ben-Shlomo, C. Metcalfe, R. Persad, 2009 .

The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study

D. Gillatt, D. Dorling, Y. Ben-Shlomo, 2008, BJU international.

The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study.

David Gillatt, Raj Persad, Yoav Ben-Shlomo, 2007, European urology.

DIFFERENCES IN THE EPIDEMIOLOGY AND PRESENTATION OF PROSTATE CANCER IN BLACK AND WHITE MEN IN ENGLAND: LESSONS LEARNT FROM THE PROCESS STUDY

Y. Ben-Shlomo, C. Metcalfe, G. Muir, 2009, BJU international.

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

J. Sterne, F. Hamdy, D. Neal, 2018, JAMA.

Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of Hospital Episodes Statistics for England

J. Verne, D. Gunnell, Richard M. Martin, 2007, BJU international.

Prostate cancer and urinary incontinence.

S. Evans, B. Parsons, M. Wright, 2009, Maturitas.

Investigating Black‐White differences in prostate cancer prognosis: A systematic review and meta‐analysis

Y. Ben-Shlomo, C. Metcalfe, R. Persad, 2008, International journal of cancer.

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

J. Sterne, F. Hamdy, D. Neal, 2014, British Journal of Cancer.

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

J. Oxley, J. Sterne, F. Hamdy, 2016, British Journal of Cancer.

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

F. Hamdy, D. Neal, J. Donovan, 2015, BMC Medical Research Methodology.

Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study

D. Gillatt, Y. Ben-Shlomo, C. Metcalfe, 2008, British Journal of Cancer.

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial

F. Hamdy, D. Neal, J. Donovan, 2015, BMJ Open.